(703) 791-9099 | VN Tiếng Việt

Is ADHD
genetic?

Written & medically reviewed by Alice Tran, PMHNP-BC  ·  July 2026  ·  8 min read

Yes, ADHD is one of the most heritable conditions in all of psychiatry. But heritability does not mean destiny, and understanding the genetics of ADHD can help families make sense of their experiences.

The Heritability of ADHD

Decades of family, twin, and adoption studies have established that ADHD runs in families. The heritability of ADHD, the proportion of variation in the trait attributable to genetic factors, is estimated at approximately 70 to 80%, making it comparable to the heritability of height. A comprehensive review in Molecular Psychiatry confirmed a heritability of 74%, and a 2026 narrative review for clinicians reaffirmed that ADHD is "highly heritable (~70%), comparable to other major neuropsychiatric conditions."

To put this in perspective: if one identical twin has ADHD, the other twin has roughly a 70 to 80% chance of also having it. If a parent has ADHD, their child has a significantly elevated risk of the condition. This strong genetic component is one reason why, when a child is diagnosed with ADHD, parents often recognize the same traits in themselves.

What Genetic Studies Have Found

The genetics of ADHD are complex. There is no single "ADHD gene." Instead, ADHD is polygenic, meaning thousands of common genetic variants each contribute a small amount of risk. The largest genome-wide association study (GWAS) to date, involving over 38,000 individuals with ADHD and 186,000 controls, identified 27 genome-wide significant risk loci and highlighted 76 potential risk genes. These genes are enriched among those expressed during early brain development and in midbrain dopaminergic neurons, consistent with the longstanding understanding that dopamine signaling plays a central role in ADHD.

Importantly, these common variants collectively account for about a third of ADHD's heritability. Rare genetic variants, including copy number variants (insertions or deletions of DNA segments), also contribute. Studies have found that rare copy number variants are more frequent in individuals with ADHD than in controls, and some of these overlap with variants found in autism spectrum disorder, reflecting the genetic overlap between neurodevelopmental conditions.

Bivariate modeling estimates that 84 to 98% of ADHD-influencing variants are shared with other psychiatric disorders, which helps explain why ADHD so frequently co-occurs with conditions like anxiety, depression, and autism.

Genes Are Not the Whole Story

While genetics account for the majority of ADHD risk, environmental factors also play a role. Prenatal and perinatal risk factors, including prematurity and low birthweight, have been consistently associated with ADHD, and family studies suggest these effects cannot be fully explained by genetic confounding. Intrauterine exposure to tobacco and maternal stress during pregnancy are also associated with ADHD, though these associations may be partly explained by shared genetic factors.

Postnatal environmental factors, including exposure to artificial food colorings and environmental pollutants, have been studied, but the effects are small and largely correlational. Importantly, although associations between ADHD and parenting style have been noted, they are likely due to an evocative gene-environment correlation, meaning the child's ADHD-related behavior elicits certain parenting responses, rather than the parenting causing ADHD.

What This Means in Practice

There are currently no diagnostic genetic tests for ADHD. A 2026 clinical review emphasized that "assessment should prioritize functional impairment, developmental and family history, and comorbidity" rather than genetic testing. However, there is one area where genetics has practical clinical relevance: pharmacogenetics. CYP2D6 genotyping can guide dosing of atomoxetine (a non-stimulant ADHD medication), though routine genetic testing for stimulant medication selection is not currently justified.

For families, understanding the genetic basis of ADHD can be profoundly validating. It confirms that ADHD is a neurobiological condition, not a character flaw, a parenting failure, or a lack of willpower. Psychoeducation should emphasize modifiable risk factors and the interplay of genes and environment, while reassuring families that effective treatments exist regardless of the underlying genetic architecture.

ADHD runs in your family? Get a real answer.

Alice Tran, PMHNP-BC, provides psychiatric evaluations, medication management, and supportive therapy, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. No referral needed.

Schedule a Consultation

See Also

What to Expect at Your ADHD Evaluation → Understanding Your Genetic Test: A Patient Guide → Why Wasn't My ADHD Diagnosed as a Child? →

Sources

  • Faraone SV, Larsson H. "Genetics of attention deficit hyperactivity disorder." Molecular Psychiatry, 2019.
  • Demontis D, et al. "Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains." Nature Genetics, 2023.
  • Faraone SV, et al. "The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder." Neuroscience & Biobehavioral Reviews, 2021.
Anh Tran (Alice), PMHNP-BC, FNP-BC

Anh Tran (Alice), PMHNP-BC, FNP-BC

Dual Board-Certified Family and Psychiatric Nurse Practitioner

Alice is a dual board-certified PMHNP and FNP licensed in Virginia, trained under psychiatrist Dr. Errol Segall, MD (50+ years of experience). She treats ADHD, anxiety, depression, and more, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. Learn more →